第107回Ġ

C7Lk_抄読会
2012 Â 3 à 21 Ü
Ö¼ĞĐ´×·umĪñ¶Effectiveness of Reirradiation for painful Bone Metastases: A Systematic Reviewand Meta-Analysis
Merel Huisman et al.
Int J Radiation Oncol Biol Phys, 2012 Jan 31.
Abstract
Purpose: ¤Ö¼ĞïĆÇ"Ą)"ć!»0áĄÊőĻđ"Ëģ"ß­ 42%!¶Û10čĒ¨

÷¼4

÷¼#Ö¼ĞïĆ4Ëģ%"Ą)"DhPfkd"ç!Ŋ

(o0x¤"FHN^N8MAeWak`J7RcFH

#áĄÊőĻđ!»0

÷¼!-0Ą)"DhPfkd!»0ç4µŇ04ĊĈ0Methods and Materials: Ńèä{4ó*!MEDLINE, EMBASE, Cochrane Library"OkJ[kH4þÙéĘ4¶ÛHJO8"ńÐ¡ĹĲ4īÇĻđ!0őĄ%"÷¼!»0ăĄÉ4î*Results: éĘÙú 707 ğ"FHN^N8MAeWak`J7RcFH
İ 10 ğ4ÑHJO8"¡Ĺ#(/ 2,694 "Ëģ" ÷¼4

(10Ŗğ"Ļđ!-0őĄ%"ïĆ4â!

"# 527 (20%)0 ÷¼Ç"ăĄÉ# 527

q 58%(ě¯û 0.58, 95%CI 0.490.67)HJO8"ŉ!#ĨÃĈ"ł

0"čĒŉ"āĹÊ

Conclusions: áĄÊőĻđ"4Ëģ"ė 40%!ç`J7RcFH#ÓĈ(I2 ěİŇ 63.3%, p=0.01)

÷¼#3È.1

ĝÓ

ł,Úð

"À

.Ëģ%"ŌĄçĮ.1ęç"³ÆÊ#ŋµĈ0÷¼"ç!»0-/µŇĈ÷¼

1+x¤"

Ĳ4p

1[½]!

)êĖ# 1 ¤÷¼

ĞŇ4ď?9Qb9h
Ąû!À
!

(Üã"©Õ°10ÚőĻđ!»0Ö¼ĞïĆ"ĞŇHCGakd#((Į.1

,ĸþŎŔ¤÷¼"Ú

áĄÊőĻđ!»0Ö¼ĞïĆ#

!

HJhKkQ0ýÿŌ

ķÒ

¾



- 6070%'ŌĄm.10ĮĽ*0÷¼4Ûī0ä{
1. ß"Ö¼ĞïĆÇ!ŌĄ

Ą)"Łī

0

2. ¤ïĆÇ! PR .!Ö¼Ğ4÷¼Ą)4ļò3. ¤ïĆ PR , CR Ç"Ą)"ć!

¤Ö¼ĞïĆÇß­ 40%"ËģŌĄ

È.1!

¤Ö¼ĞïĆÇ1 Âz!ăĄ

!

÷¼4

.1/3  CR !

0

ć0Ëģ#ė 50%0Ëģ# 8%42%¤!÷¼4

w-/Ŕ¤÷¼4w¬!

áĄÊőĻđ!

x("2!

ü¥áĄÊőĻđ"÷¼4

0Ëģ#¬

(;WOhH

÷¼"ZfH\AN8YHJO8#ćĬ1
÷¼"ĞŇ!Ŋ0 RCT (RC20)ī310[Úð»Ķ]!

MEDLINE, EMBAS, Cochrane Library  painful bone metastases, radiotherapy,reirradiation !ŊĿ0gkQÙéĘ!

ċv÷ÑĵÙ!Ŋ#ĵÙĵĳFHN^N8MAeWak×ĐÞćĬ1!

.#ÑrĭĊĈ#¤Ö¼ĞïĆËģ%"

!

HJO8

ŌĄ4È.1.Ñ

¤ïĆÇćáĄÊőĻđ

÷¼Ç"ăĄÉ"ĲHJO8"ńÐ§ô1. ¤Ö¼ĞïĆŅ}0
2. ¤ïĆ3.

÷¼+«÷¼0

÷¼Ç"ăĄÉ!Ŋ07:P>_¨10

4. =cGRd"čĒęç¨10!

OkJ"Ñ¡ĹĲŗZb9^ck;hQ]9hPŘăĄÉûăĄÉû=PR, CR,
ORI>hKck;hQ]9hP=

÷¼!-0á¸tĶăĄÉâŉ¹įÔĜâŉÑOkJ#ËģùÊïĆùÊăĄÉHJO8¡ĹVb`kJ!

ěİÏð:R 2. 13. 0 (Metafor package version 1. 6-0)4þáÍÀ# p<0.05 µġø
U97H"Ĳ!X6hSdZfMP4~I2 ěİŇ# 63.3% (p=0.01)
2

[ęç]!

HJO8"ńÐŗ707 ğ→J9PdĽ)→qĺ

!

. 87 ğ%Ě/Ľ)→7YHPbAP. 28 ğ%Ě/.Ě/Ľ)ċv÷ 3 ğ10 ğ%Ě/Ľ)

HJO8"ãå"ĊĈ……

÷¼

ãå"ĊĈ#

EYBdkZ!Ő10+"+0!

3/10 ğ#`J7RcFH!

ĞŇHCGakd!

ăĄÉ#cM>kPHCkd (Ą)

ěl10"# 3/7 ğļÄqĔÄņÄ)ěl1(van der Linden etal., 2004.# 11 ŏĊ)Ĺ¢Ĭ¤ĕ!

ăĄ"Ĳâŉ# Hoskin et al.")÷¼Ç 1 iàěl10

÷¼Ëģ"[kHb9hùÊ!

2,694 q 527  (20%)

÷¼4¶ÛHJO8"ËģØ!»0

÷¼"#11%42%
!

ăĄÉ# 527 q 440  (84%)î*.1÷¼Ëģ"[kHb9hùÊ# van der Linden et al, 2004. (ĀÊ: 61%, ±Ê: 39%Âœq!

®: 65 ëÁ¦>dTXH@kVX<k^hHHD7=70 õ) Hayashi et al. (ĀÊ: 57%±Ê: 43%Âœq®: 60 ëÁ¦ ECOG VX<k^hHHD7=2.5)z«¨!

ć¿#s

5: 33%, ēħ

5: 23%, Ĥ 5: 23%, "y: 23%

÷¼ĻđŅ#ĦŒ: 36%, őĉ: 38%, ć¿"ľ}!0ňő: 12%, "y: 14%

!

ăĄÉ!

264/440 ! CR!

CR û# 16%28%PR û# 28%45%

!

÷¼ÇŌĄ

PROR=58% (95% CI=0.49-0.67)
ü10("âŉ# 3 ŀ5 ŀ¹įÔĜâŉ# 15 ŀ22 ŀá¸tĶ
!

Rotterdam Symptom Checklist  31%"Ëģ

HD7ŕ­Ņ£íj£ņÄ"ĂÎ!-0 (van der Linden et al.)
!

30%"ËģBekQ 12 ­Ņ£íj£ną!-0 (Jeremic et al., 1999)

[Ģº]!
!
!

÷¼4

 527 / 2,694 " 58%!ç÷¼ì&l¤÷¼"Ú
÷¼Ç"Ą)"ļò#È.1öªÌâŉČ;WOhH#

- 35 ŀŉÇ3!

¹įÔĜâŉ# 15 ŀ22 ŀ!

ĲĥËģ"¤Ö¼ĞïĆÇ"¯û# 7074%ITT įæ# 58%60%

!

x(Ö¼ĞōïÊ"őĄ%"#((1.

ė÷¼! RCT

÷¼"áÊ4éıHJO8

2. ËģØ
3.

¾-



÷¼"ýÿ

6. ¤ïĆ

.

ĩŃĞŇ#1

÷¼#Ďē1

4. ŌĄ";hQ]9hP"µġ
5.

¾



÷¼!Ŋ0?9Qb9h.

*x¤"`J7RcFHÝĎ

1 ¤÷¼÷¼"*čĒŉ"o¦ĹÊÅ$.0

÷¼4ī("âŉģ¤Ö¼ĞïĆ

..¾

ěl1

+ 4 ŀŉÇ!

HJO8+).10→¬

÷¼4©#ç"Ë

0

[ęĵ]
!

x(-/+ÓĈµŇĈ!

Ö¼ĞōïÊ"őĄ!»
1

÷¼"áÊ
÷¼#3

È.1
.çĮ.1ė 40%#çÈ.

4